BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33998851)

  • 1. Attitudes and Beliefs Toward Cannabis Before Recreational Legalization: A Cross-Sectional Study of Community Adults in Ontario.
    Turna J; Balodis I; Van Ameringen M; Busse JW; MacKillop J
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):526-536. PubMed ID: 33998851
    [No Abstract]   [Full Text] [Related]  

  • 2. Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students.
    Vujcic I; Pavlovic A; Dubljanin E; Maksimovic J; Nikolic A; Sipetic-Grujicic S
    Subst Use Misuse; 2017 Jul; 52(9):1225-1231. PubMed ID: 28605305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis Use Frequency and Cannabis-Related Consequences in High-Risk Young Adults Across Cannabis Legalization.
    Doggett A; Belisario K; McDonald AJ; Ferro MA; Murphy JG; MacKillop J
    JAMA Netw Open; 2023 Sep; 6(9):e2336035. PubMed ID: 37755827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
    Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
    Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario.
    AminiLari M; Busse JW; Turna J; MacKillop J
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1133-1139. PubMed ID: 35333612
    [No Abstract]   [Full Text] [Related]  

  • 6. Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies.
    Sznitman SR; Bretteville-Jensen AL
    Harm Reduct J; 2015 Oct; 12():46. PubMed ID: 26467203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Cannabis Use During the Reproductive Cycle: A Retrospective Cross-Sectional Study of Women in States With Recreational and Medical Cannabis Legalization.
    Taylor DL; Bell JF; Adams SL; Drake C
    Matern Child Health J; 2021 Sep; 25(9):1491-1500. PubMed ID: 34155601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada.
    Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL
    JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
    Hawley P; Gobbo M; Afghari N
    BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017.
    Kim JH; Weinberger AH; Zhu J; Barrington-Trimis J; Wyka K; Goodwin RD
    Drug Alcohol Depend; 2021 Jan; 218():108364. PubMed ID: 33143941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.
    Shi Y
    Addiction; 2021 Jul; 116(7):1782-1793. PubMed ID: 33217090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020.
    Okey SA; Castro SA; Waddell JT; Jones CB; Blake AJ; O'Rourke HP; Davis MC; Meier MH
    Int J Drug Policy; 2022 Feb; 100():103531. PubMed ID: 34818602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study.
    Kim C; Chum A; Nielsen A; Allin S; Penney TL; Rittenbach K; MacMaster FP; O'Campo P
    PLoS One; 2022; 17(10):e0268718. PubMed ID: 36288275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis health knowledge and risk perceptions among Canadian youth and young adults.
    Leos-Toro C; Fong GT; Meyer SB; Hammond D
    Harm Reduct J; 2020 Aug; 17(1):54. PubMed ID: 32746859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
    Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
    JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization.
    Myran DT; Gaudreault A; Pugliese M; Manuel DG; Tanuseputro P
    JAMA Netw Open; 2023 Sep; 6(9):e2331551. PubMed ID: 37672273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes Toward Cannabis Use Legalization and Openness to Legal Use Among Young Partygoers in Norway.
    Burdzovic Andreas J; Bretteville-Jensen AL; Gjersing L
    J Stud Alcohol Drugs; 2023 Jan; 84(1):51-57. PubMed ID: 36799674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeking safety: a focus group study of young adults' cannabis-related attitudes, and behavior in a state with legalized recreational cannabis.
    Amroussia N; Watanabe M; Pearson JL
    Harm Reduct J; 2020 Nov; 17(1):92. PubMed ID: 33243280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada.
    Anderson KK; Rodrigues R; Le B; Mamun M; Archie S; Edwards J; Elton-Marshall T; Gilliland J; Myran DT; Palaniyappan L; Perlman CM; Seabrook JA; Murray RM; Shariff SZ
    Int J Drug Policy; 2024 Jan; 123():104285. PubMed ID: 38071933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.